Immunoprecise Antibodies Ltd
XTSX:IPA
Immunoprecise Antibodies Ltd
XTSX:IPA
Price:
6.5
CAD
0.78%
Market Closed
Market Cap:
CA$161.4m
Relative Value
There is not enough data to reliably calculate the relative value of IPA.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
IPA
Relative Value
Base Case
Not Available
Multiples Across Competitors
IPA Competitors Multiples
Immunoprecise Antibodies Ltd Competitors
Immunoprecise Antibodies Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Immunoprecise Antibodies Ltd
XTSX:IPA
|
161.4m CAD | 8.5 | -9.4 | -15.2 | -8.6 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD | 368.3 | 4 361 | 1 382.7 | 2 954.2 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
195.3B USD | 4.4 | 29.1 | 20.3 | 27.3 | |
| US |
|
Danaher Corp
NYSE:DHR
|
147.9B USD | 6 | 40.9 | 20.6 | 30 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
79.2T KRW | 14.4 | 49.6 | 29.1 | 38.8 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
36.8B CHF | 5.6 | 38.9 | 28.7 | 28.7 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
274.9B CNY | 6.2 | 18.3 | 18.5 | 18.5 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
34.2B USD | 4.8 | 26.5 | 20.8 | 24.9 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.9B USD | 1.8 | 22 | 12.1 | 18.2 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
27.8B USD | 6.9 | 32 | 23.6 | 26.2 | |
| CN |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
157.4B HKD | 7 | 33.3 | 23.3 | 23.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
